(Circulation. 2001;104:2412.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Feinberg Cardiovascular Research Institute (F.J.K., R.M.J., R.J.K., K.R.H., S.H., D.S.F., S.M., V.C., M.A.P.) and Departments of Medicine (F.J.K., R.M.J., R.J.K.) and Biomedical Engineering (F.J.K., R.M.J.), Northwestern University School of Medicine, and Siemens Medical Systems (O.P.S.), Chicago, Ill. Dr Miller is now at Radiologische Diagnostik, Uniklinik Tübingen, Hoppe-Seyler-Straße 3, D-72076 Tübingen, Germany.
Reprint requests to Francis J. Klocke, MD, Tarry 12-703 (T233), Northwestern University Medical School, 303 E Chicago Ave, Chicago, IL 60611-3008. E-mail f-klocke{at}northwestern.edu
| Abstract |
|---|
|
|
|---|
Methods and Results Graded regional differences in vasodilated flow were produced in chronically instrumented dogs with either left circumflex (LCx) infusion of adenosine or partial LCx occlusion during global coronary vasodilation. First-pass myocardial signal intensity-time curves were obtained after right atrial injection of gadoteridol (0.025 mmol/kg) with an MRI inversion recovery true-FISP sequence. The area under the initial portion of the LCx curve was compared with that of a curve from a remote area of the ventricle. Relative LCx and remote flows were assessed simultaneously with microspheres. The ratio of LCx and remote MRI curve areas and the ratio of LCx and remote microsphere concentrations were highly correlated and linearly related over a 5-fold range of flow differences (y=0.96 x±0.07, P<0.0001, r2=0.87). The 95% confidence limits for individual MRI measurements were ±35%. Regional differences of
2-fold were consistently apparent in unprocessed MR images.
Conclusions Clinically relevant regional reductions in vasodilated flow in viable myocardium can be detected with 95% confidence over the range of 1 to 5 times resting flow. This suggests that MRI can identify and quantify limitations in perfusion reserve that are expected to be produced by stenoses of
70%.
Key Words: magnetic resonance imaging regional blood flow vasodilation
| Introduction |
|---|
|
|
|---|
The identification of a regional limitation in flow reserve in viable myocardium is based on the identification of a relative reduction in perfusion during coronary vasodilation. Pharmacological vasodilation can increase resting flow 4- to 8-fold in normally perfused viable tissue, whereas a lesser increase occurs in areas supplied by stenotic arteries. 1,2 Because 70% diameter stenoses reduce vasodilated flow by only
50%, 25 a clinically useful technique needs to identify 2-fold regional differences in vasodilated flow consistently. This is an appreciably more demanding requirement than when perfusion imaging is used to identify areas of myocardial infarction, ie, resting blood flow in infarcted tissue is no more than 10% to 20% of resting flow in adjacent viable tissue, and this 5- to 10-fold difference under resting conditions can increase to 20- to 50-fold during pharmacological vasodilation.
The present study was undertaken to define the limits of detection of regional differences in vasodilated coronary flow in viable myocardium with a first-pass MRI approach combining inversion recovery with a rapid-acquisition true-FISP (fast imaging with steady-state precision) sequence having an unusually favorable signal-to-noise ratio. 6,7 Regional differences in first-pass MR curves were compared with the regional distribution of systemically administered microspheres in chronically instrumented dogs.
| Methods |
|---|
|
|
|---|
Experimental Preparation
Twelve animals weighing 25 to 30 kg were instrumented after an overnight fast and a 3-week period of on-site conditioning. Details of the instrumentation procedure have been published previously. 8 The proximal portion of the left circumflex artery (LCx) was instrumented with a 22-gauge infusion catheter and external Doppler flowmeter and, in 3 animals, an external hydraulic occluder. Left and right atrial catheters were placed for administration of fluorescent microspheres and MR contrast agent, respectively. Animals were allowed to recover for
7 days before being studied.
Study Procedures
Animals were brought to the MR scanner, anesthetized with methohexital sodium 11 mg/kg IV, intubated, and ventilated with a commercial anesthesia machine and an oxygen-isoflurane (1.5% to 2.5%) gas mixture. Systemic O2 saturation and end-tidal PCO2 were monitored continuously (model 3150 Physiological Monitor, Invivo Research, Inc), with ventilation adjusted to maintain end-tidal PCO2 at 30 to 32 mm Hg. O2 saturation always exceeded 95%. Heart rates averaged 109±12 bpm (SD). Animals were studied in the right lateral decubitus position, with the heart located at the level of an in-table receiver coil. An additional 2-element quadrature array coil was positioned directly over the heart.
A single midventricular short axis or a longitudinal axis that included the posterior left ventricular wall was identified for study. A true-FISP inversion recovery sequence known to be very sensitive to changes in T16,7 was used for first-pass imaging. Typical parameters included an 80x256 matrix, 150x300 mm field of view, TR 3.0, TE 1.5, inversion recovery TI 250 ms, 6-mm slice thickness, and 1 image per heartbeat. The requirement of complete rewinding on all 3 gradient axes caused the repetition time (TR) to be slightly longer than spoiled gradient echo sequences, eg, turbo-FLASH (fast low-angle shot). Single-slice imaging was performed to limit the application of the 180° inversion recovery preparation pulse to once per cardiac cycle to maintain adequate signal-to-noise ratio and contrast. A sequence diagram is shown in Figure 1.
|
Steady-state increases in regional LCx flow were produced with graded LCx infusion of adenosine (0.01 to 1.0 mg/min) in 9 animals. Three animals were studied during sustained generalized coronary vasodilation produced by carbocromen (5 mg/kg IV). In these latter cases, regional LCx flow limitations were produced by partial inflation of the LCx hydraulic occluder while the Doppler velocity signal was monitored (which always remained above its prevasodilation level). MR first-pass measurements were obtained, with ventilation interrupted at end expiration. Gd-HP-DO3A (gadoteridol) 0.025 mmol · L-1 · kg-1 was injected into the right atrium over 4 seconds and followed by a 12-mL saline flush administered at 1 mL/s. This pattern of right-sided contrast injection was chosen to produce intensity-time curves in left ventricular blood similar to those seen in patients after central venous injection. The relatively low dose of contrast (0.025 mmol · L-1 · kg-1) ensured a linear response between myocardial signal and contrast concentration (Figure 2). Images were collected during each diastole for 40 to 60 beats. Fluorescent microspheres 9 (n=3x106) were injected into the left atrium immediately after each MR measurement. Up to 3 sets of MR and microsphere measurements were performed during a single study. After completion of the measurements, anesthesia was discontinued, and animals were returned to the vivarium after full recovery. Individual animals were studied on 1 to 3 occasions. When all studies had been completed, animals were euthanized with an overdose of pentobarbital, and the heart was retrieved for microsphere analysis.
|
After the most basal and apical 0.5-cm portions had been removed, the left ventricle and septum were divided into 4 or 5 short-axis slices for fluorescent microsphere analysis. Myocardial scarring was never evident. Concentrations of microspheres in individual areas of each slice were assessed fluorometrically and expressed on a per gram basis. 9
Data Analysis
Regional differences in flow were expected to produce differences in the initial portions of regional signal intensitytime curves. First-pass curves in an LCx region of interest were compared with simultaneous first-pass curves in a remote area of the ventricle, ie, the LAD bed or septum. Baseline signals measured before contrast administration were used to correct for any coil-induced differences in signal in the paired curves. These were present in
50% of cases but rarely exceeded 15%. Areas under each pair of LCx and remote curves were measured from the onset of contrast appearance to the peak of the curve showing the more rapid upslope. The ratio of areas in the LCx and remote curves was then compared with the ratio of microsphere concentrations/g myocardium in the same areas of the ventricle. The reproducibility of measurements of MRI area ratios was assessed by triplicate determinations performed on 7 occasions. Ratios averaged 1.94; the SEM of measurement was 0.28.
Because the number of comparisons of MRI and microsphere flow ratios in an individual animal varied, the linear regression of MRI flow ratio on microsphere flow ratio was calculated with and without taking into account the structure of the data with regard to repeated measurements from the same dog.10 Because the results did not differ, the data values were treated as independent pairs. When subjected to linear regression, the slope of the linear model was consistent with unity, but the residual values showed a pattern of increasing variance as flow ratios increased (P<0.0002). Accordingly, the data were fitted with a weighted linear regression model in which residual variance increases concomitantly with the independent variable. 11
| Results |
|---|
|
|
|---|
2-fold were consistently apparent in the unprocessed MR images.
|
|
|
| Discussion |
|---|
|
|
|---|
Thus, the identification of an area of viable myocardium supplied by an artery having a
70% stenosis requires a flow measurement technique that can consistently identify a 50% regional reduction in vasodilated flow. The data in Figure 5 indicate that the expected MRI flow ratio of 1.0 between 2 normally perfused territories is, at least in this experimental model, associated with 95% confidence limits of 0.65 to 1.35. An increase in this ratio to 2.0, as with a 50% reduction in vasodilated flow in a stenotic territory, is clearly beyond the limits of normal perfusion. The present findings further suggest that stenoses >70%, which are expected to produce larger regional differences in vasodilated flow, may be subdivided functionally on the basis of the relative reductions in the initial area of first-pass curves in the portions of the ventricle they supply.
The MRI area ratio "perfusion index" used in this study, like others reported in the literature, is arbitrary. Ratios of peak signal amplitudes and average curve upslopes (calculated as the quotient of the difference between baseline and peak signal values and time) were also linearly related to microsphere data. These showed poorer agreement, however (r2=0.62 and 0.70, respectively). The continued linearity of the relation between our MRI perfusion index and the corresponding microsphere perfusion index at vasodilated flows exceeding 2 to 3 times resting flows is in some respects surprising. Myocardial extraction of Gd-DTPA has been reported to vary inversely with flow,12 as is known to be the case for 99mTc-sestamibi 13 and, to a lesser degree, 201Tl. 1416 In the case of 99mTc-sestamibi, the decreasing extraction causes the relation between tracer signal and flow to plateau as flow increases to more than 2 to 3 times its resting value. The MR signal has the additional complexity of resulting not from Gd directly but rather from reductions in proton relaxation times caused by the magnetic moment associated with Gd. Because most myocardial protons are located on water molecules, rates of water exchange among the intravascular, interstitial, and intracellular compartments influence the number of water molecules affected by Gd.17,18
Most clinical studies that used first-pass perfusion imaging have focused on the identification of regional perfusion deficits indicating the presence of coronary artery disease. These have usually been observational studies in patients with already known or suspected coronary disease. A substantial portion of such patients may be expected to have had previous myocardial infarction, either silent or clinically apparent. Thus, in studies performed during pharmacological coronary vasodilation, the perfusion deficits identified have no doubt included areas of myocardial infarction as well as viable myocardium having limited coronary flow reserve. Wilke et al 19 summarized studies through 1999. Of 21 studies (which included a total of more than 500 patients), 85% used coronary vasodilation with adenosine or dipyridamole. Values of sensitivity and specificity for the identification of coronary artery disease appeared comparable to those reported for radionuclide and angiographic modalities. More recently, Al-Saadi et al20 reported that reductions in flow reserve in areas of >75% stenosis can be identified by upslope analyses of regional and left ventricular curves.
The Minnesota group developed sophisticated models for assessing myocardial flow quantitatively21 and used them to study absolute values of coronary flow reserve in a porcine preparation in which marginal branches of the circumflex artery were ligated and vasodilation was produced by systemic infusion of adenosine. 22 Microsphere flows in the anterior and septal regions averaged 430% of flow in the lateral wall at rest (1.16 versus 0.27 mL · min-1 · g-1) and 710% of flow in the lateral wall during adenosine-induced vasodilation (2.91 versus 0.41 mL · min-1 · g-1). The first-pass curves in the 2 areas were also used to derive a perfusion index similar to that reported here. The ratio of peak curve amplitudes was linearly related to the ratio of microsphere deposition in the same areas (y=0.92 x+0.098, r=0.88). In view of the low absolute values of lateral wall flow and the paucity of native collateral vessels in the porcine heart, areas of the lateral wall may have included areas of infarction.
Although measurements of a perfusion index do not provide information about absolute values of coronary flow reserve, they may still prove quite useful clinically. If first-pass vasodilated imaging is combined with additional imaging 10 to 15 minutes after contrast administration, it should be possible to determine whether areas of relative perfusion deficit originate in viable or infarcted myocardium. 2325 Although quantitative determinations of flow reserve are of great value in studying pathophysiology, they require left ventricular blood pool as well as myocardial imaging, 2 sets rather than 1 of first-pass images, and relatively complex modeling.19 The interpretation of an individual value of flow reserve can also be problematic. Although absolute values of flow reserve are reduced locally beyond stenotic lesions, they are also reduced diffusely by processes seen commonly in coronary patients, eg, hypertrophy and small-vessel disease. Additional variability in absolute values of flow reserve that is unrelated to the degree of stenosis can be produced by hemodynamically induced variations in resting flow, reductions in vasodilated flow secondary to adenosine- or dipyridamole-induced reductions in blood pressure, and other factors. 5
Although the inversion recovery true-FISP sequence provides improved image quality, it currently has significant limitations. Perhaps the most important of these is that only a single myocardial slice is imaged during each cardiac cycle. Other options, eg, imaging 2 slices every other beat, imaging 2 slices during different portions of each cardiac cycle, or 3D imaging may prove possible. Although multislice images can be obtained during individual beats if the true-FISP sequence is used with saturation recovery rather than inversion recovery, image quality is less satisfactory in our experience. Variations in cardiac cycle length that are sufficient to interrupt every-beat imaging present an additional problem, because they disturb the steady-state conditions required for inversion recovery true-FISP imaging.
In summary, with an inversion recovery true-FISP sequence having improved signal-to-noise characteristics, regional differences in flow in viable vasodilated myocardium were visually apparent in MR images obtained with a conventional contrast agent. Regional differences as small as 2-fold could be identified consistently in first-pass signal intensityversus-time curves and were quantitatively related to differences in the areas subtended by the early portion of the regional first-pass curves.
| Acknowledgments |
|---|
Received June 21, 2001; revision received August 31, 2001; accepted September 5, 2001.
| References |
|---|
|
|
|---|
2.
Wilson RF, Marcus ML, White CW. Prediction of the physiologic significance of coronary arterial lesions by quantitative lesion geometry in patients with limited coronary artery disease. Circulation. 1987; 75: 723732.
3. Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol. 1974; 34: 4855.[Medline] [Order article via Infotrieve]
4.
Gould KL. Pressure-flow characteristics of coronary stenoses in unsedated dogs at rest and during coronary vasodilation. Circ Res. 1978; 43: 242253.
5.
Klocke FJ. Measurements of coronary flow reserve: defining pathophysiology versus making decisions about patient care. Circulation. 1987; 76: 11831189.
6. Oppelt A, Graumann R, Barfuß H, et al. FISP: a new fast MRI sequence. Electromedica. 1986; 54: 1518.
7. Scheffler K, Hennig J. T1 quantification with inversion recovery true-FISP. Magn Reson Med. 2001; 45: 700723.[Medline] [Order article via Infotrieve]
8. Sherman AJ, Harris KR, Hedjbeli S, et al. Proportionate reversible decreases in systolic function and myocardial oxygen consumption after modest reductions in coronary flow: hibernation versus stunning. J Am Coll Cardiol. 1997; 29: 16231631.[Abstract]
9.
Glenny RW, Bernard S, Brinkley M. Validation of fluorescent-labeled microspheres for measurement of regional organ perfusion. J Appl Physiol. 1993; 74: 25852597.
10. S-PLUS 2000: Guide to Statistics V. Seattle, Wash: MathSoft; 1999: 417424.
11. Neter J, Wasserman W. Applied Linear Statistical Models. Homewood, Ill: Richard D. Irwin Inc; 1974: 131136.
12. Tong CY, Prato FS, Wisenberg G, et al. Measurement of the extraction efficiency and distribution volume for Gd-DTPA in normal and diseased canine myocardium. Magn Reson Med. 1993; 30: 337346.[Medline] [Order article via Infotrieve]
13.
Glover DK, Okada RD. Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole. Circulation. 1990; 81: 628637.
14.
Beller GA, Holzgrefe HH, Watson DD. Effects of dipyridamole-induced vasodilation on myocardial uptake and clearance kinetics of thallium-201. Circulation. 1983; 68: 13281338.
15.
Grunwald AM, Watson DD, Holzgrefe HH Jr, et al. Myocardial thallium-201 kinetics in normal and ischemic myocardium. Circulation. 1981; 64: 610618.
16.
Leppo JA, Meerdink DJ. Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium. Circ Res. 1989; 65: 632639.
17. Judd RM, Atalay MK, Rottman GA, et al. Effects of myocardial water exchange on T1 enhancement during bolus administration of MR contrast agents. Magn Reson Med. 1995; 33: 215223.[Medline] [Order article via Infotrieve]
18. Wilke N, Kroll K, Merkle H, et al. Regional myocardial blood volume and flow: first-pass MR imaging with polylysine-Gd-DTPA. J Magn Reson Imaging. 1995; 5: 227237.[Medline] [Order article via Infotrieve]
19. Wilke NM, Jerosch-Herold M, Zenovich A, et al. Magnetic resonance first-pass myocardial perfusion imaging: clinical validation and future applications. J Magn Reson Imaging. 1999; 10: 676685.[Medline] [Order article via Infotrieve]
20.
Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation. 2000; 101: 13791383.
21.
Kroll K, Wilke N, Jerosch-Herold M, et al. Modeling regional myocardial flows from residue functions of an intravascular indicator. Am J Physiol. 1996; 271: H1643H1655.
22.
Wilke N, Jerosch-Herold M, Wang Y, et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology. 1997; 204: 373384.
23.
Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999; 100: 19922002.
24.
Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000; 343: 14451453.
25. Wu E, Judd RM, Vargas J, et al. Visualisation of presence, location and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001; 357: 2128.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
K. H. Schuleri, G. S. Feigenbaum, M. Centola, E. S. Weiss, J. M. Zimmet, J. Turney, J. Kellner, M. M. Zviman, K. E. Hatzistergos, B. Detrick, et al. Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy Eur. Heart J., November 2, 2009; 30(22): 2722 - 2732. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Lee and N. P. Johnson Quantification of Absolute Myocardial Blood Flow by Magnetic Resonance Perfusion Imaging J. Am. Coll. Cardiol. Img., June 1, 2009; 2(6): 761 - 770. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Klem, S. Greulich, J. F. Heitner, H. Kim, H. Vogelsberg, E.-M. Kispert, S. R. Ambati, C. Bruch, M. Parker, R. M. Judd, et al. Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women. J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 436 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Selvanayagam Women with chest pain expanding the diagnostic armamentarium. J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 446 - 449. [Full Text] [PDF] |
||||
![]() |
K. H. Schuleri, L. C. Amado, A. J. Boyle, M. Centola, A. P. Saliaris, M. R. Gutman, K. E. Hatzistergos, B. N. Oskouei, J. M. Zimmet, R. G. Young, et al. Early improvement in cardiac tissue perfusion due to mesenchymal stem cells Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2002 - H2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Fenchel, A Franow, P Martirosian, M Engels, U Kramer, N I Stauder, U Helber, H Vogler, C D Claussen, and S Miller 1 M Gd-chelate (gadobutrol) for multislice first-pass magnetic resonance myocardial perfusion imaging Br. J. Radiol., November 1, 2007; 80(959): 884 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Selvanayagam, A. S.H. Cheng, M. Jerosch-Herold, K. Rahimi, I. Porto, W. van Gaal, K. M. Channon, S. Neubauer, and A. P. Banning Effect of Distal Embolization on Myocardial Perfusion Reserve After Percutaneous Coronary Intervention: A Quantitative Magnetic Resonance Perfusion Study Circulation, September 25, 2007; 116(13): 1458 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Barmeyer, A. Stork, K. Muellerleile, C. Tiburtius, A. K. Schofer, T. A. Heitzer, T. Hofmann, G. Adam, T. Meinertz, and G. K. Lund Contrast-enhanced Cardiac MR Imaging in the Detection of Reduced Coronary Flow Velocity Reserve Radiology, May 1, 2007; 243(2): 377 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Rosen, J. A.C. Lima, K. Nasir, T. Edvardsen, A. R. Folsom, S. Lai, D. A. Bluemke, and M. Jerosch-Herold Lower Myocardial Perfusion Reserve Is Associated With Decreased Regional Left Ventricular Function in Asymptomatic Participants of the Multi-Ethnic Study of Atherosclerosis Circulation, July 25, 2006; 114(4): 289 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Cury, C. A. M. Cattani, L. A. G. Gabure, D. J. Racy, J. M. de Gois, U. Siebert, S. S. Lima, and T. J. Brady Diagnostic Performance of Stress Perfusion and Delayed-Enhancement MR Imaging in Patients with Coronary Artery Disease. Radiology, July 1, 2006; 240(1): 39 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Selvanayagam, M. Jerosch-Herold, I. Porto, D. Sheridan, A. S.H. Cheng, S. E. Petersen, N. Searle, K. M. Channon, A. P. Banning, and S. Neubauer Resting Myocardial Blood Flow Is Impaired in Hibernating Myocardium: A Magnetic Resonance Study of Quantitative Perfusion Assessment Circulation, November 22, 2005; 112(21): 3289 - 3296. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fenchel, A. Franow, N. I. Stauder, U. Kramer, U. Helber, C. D. Claussen, and S. Miller Myocardial Perfusion after Angioplasty in Patients Suspected of Having Single-Vessel Coronary Artery Disease: Improvement Detected at Rest-Stress First-Pass Perfusion MR Imaging--Initial Experience Radiology, October 1, 2005; 237(1): 67 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fenchel, U. Helber, U. Kramer, N. I. Stauder, A. Franow, C. D. Claussen, and S. Miller Detection of Regional Myocardial Perfusion Deficit Using Rest and Stress Perfusion MRI: A Feasibility Study Am. J. Roentgenol., September 1, 2005; 185(3): 627 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fuster and R. J. Kim Frontiers in Cardiovascular Magnetic Resonance Circulation, July 5, 2005; 112(1): 135 - 144. [Full Text] [PDF] |
||||
![]() |
I. Klem, W. G. Rehwald, J. F. Heitner, A. Wagner, T. Albert, M. A. Parker, E.-L. Chen, R. J. Kim, and R. M. Judd Noninvasive Assessment of Blood Flow Based on Magnetic Resonance Global Coherent Free Precession Circulation, March 1, 2005; 111(8): 1033 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Fieno, S. M. Shea, Y. Li, K. R. Harris, J. P. Finn, and D. Li Myocardial Perfusion Imaging Based on the Blood Oxygen Level-Dependent Effect Using T2-Prepared Steady-State Free-Precession Magnetic Resonance Imaging Circulation, September 7, 2004; 110(10): 1284 - 1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.H. Giang, D. Nanz, R. Coulden, M. Friedrich, M. Graves, N. Al-Saadi, T.F. Luscher, G.K. von Schulthess, and J. Schwitter Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first european multi-centre experience Eur. Heart J., September 2, 2004; 25(18): 1657 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Edelman Contrast-enhanced MR Imaging of the Heart: Overview of the Literature Radiology, September 1, 2004; 232(3): 653 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Christian, D. W. Rettmann, A. H. Aletras, S. L. Liao, J. L. Taylor, R. S. Balaban, and A. E. Arai Absolute Myocardial Perfusion in Canines Measured by Using Dual-Bolus First-Pass MR Imaging Radiology, September 1, 2004; 232(3): 677 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.D. Wolff, J. Schwitter, R. Coulden, M.G. Friedrich, D.A. Bluemke, R.W. Biederman, E.T. Martin, A.J. Lansky, F. Kashanian, T.K.F. Foo, et al. Myocardial First-Pass Perfusion Magnetic Resonance Imaging: A Multicenter Dose-Ranging Study Circulation, August 10, 2004; 110(6): 732 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Lee, O. P. Simonetti, K. R. Harris, T. A. Holly, R. M. Judd, E. Wu, and F. J. Klocke Magnetic Resonance Versus Radionuclide Pharmacological Stress Perfusion Imaging for Flow-Limiting Stenoses of Varying Severity Circulation, July 6, 2004; 110(1): 58 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shan, G. Constantine, M. Sivananthan, and S. D. Flamm Role of Cardiac Magnetic Resonance Imaging in the Assessment of Myocardial Viability Circulation, March 23, 2004; 109(11): 1328 - 1334. [Full Text] [PDF] |
||||
![]() |
E. Nagel, C. Klein, I. Paetsch, S. Hettwer, B. Schnackenburg, K. Wegscheider, and E. Fleck Magnetic Resonance Perfusion Measurements for the Noninvasive Detection of Coronary Artery Disease Circulation, July 29, 2003; 108(4): 432 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Foltz, H. Huang, S. Fort, and G. A. Wright Vasodilator Response Assessment in Porcine Myocardium With Magnetic Resonance Relaxometry Circulation, November 19, 2002; 106(21): 2714 - 2719. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |